NUCLEAR-CYTOPLASMIC TRANSPORT IS A THERAPEUTIC TARGET IN MYELOFIBROSIS

PURPOSE: Myelofibrosis (MF) is a hematopoietic stem cell neoplasm characterized by bone marrow reticulin fibrosis, extramedullary hematopoiesis, and frequent transformation to acute myeloid leukemia. Constitutive activation of JAK/STAT signaling through mutations in JAK2, CALR, or MPL is central to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cancer Res
Autors principals: Yan, Dongqing, Pomicter, Anthony D., Tantravahi, Srinivas K., Mason, Clinton C., Senina, Anna V., Ahmann, Jonathan M., Wang, Qiang, Than, Hein, Patel, Ami B., Heaton, William L., Eiring, Anna M., Clair, Phillip M., Gantz, Kevin C., Redwine, Hannah M., Swierczek, Sabina I., Halverson, Brayden J., Baloglu, Erkan, Shacham, Sharon, Khorashad, Jamshid S., Kelley, Todd W., Salama, Mohamed E., Miles, Rodney R., Boucher, Kenneth M., Prchal, Josef T., O'Hare, Thomas, Deininger, Michael W.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6445677/
https://ncbi.nlm.nih.gov/pubmed/30563936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-0959
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars